Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2018 -2019
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2019

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
Version / remarks:
25 Jun 2018
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: EURL ECVAM DB-ALM Method Summary No. 164: EpiOcular™ Eye Irritation Test
Version / remarks:
Summary, 22 July 2015
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: EpiOcular™ Eye Irritation Test (OCL-200-EIT) For the prediction of acute ocular irritation of chemicals For use with MatTek Corporation’s Reconstructed Human EpiOcular™ Model
Version / remarks:
29 June 2015
Deviations:
no
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
EC Number:
252-939-2
EC Name:
Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
Cas Number:
36265-41-5
Molecular formula:
C33H59NO4
IUPAC Name:
didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate
Test material form:
solid: particulate/powder

Test animals / tissue source

Details on test animals or tissues and environmental conditions:
The EpiOcular™ tissues are provided as kits (e.g. OCL-200-EIT; MatTek), consisting of the following components relevant for this study:
1x sealed 24-well plate containing 24 inserts with EpiOcular™ tissues on agarose
1x bottle EpiOcularTM assay medium
1x bottle Ca2+/Mg2+-free DPBS buffer

Test system

Vehicle:
water
Controls:
yes

Results and discussion

In vitro

Results
Irritation parameter:
in vitro irritation score
Value:
108
Negative controls validity:
valid

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In this study under the given conditions the test item showed no irritant effects. The relative mean viability of the test item treated tissues was 108 %. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.
Executive summary:

In the present study the eye irritating potential of Didodecyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate was analysed. Since irritant substances are cytotoxic to the corneal epithelium after a short time exposure the cytotoxic effects of the test item on EpiOcular, a reconstituted three-dimensional human corneal epithelium model, were determined. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 6 h exposure period and 18 h post-treatment period and compared to those of the concurrent negative controls.

The mixture of 50 mg test item per 1 mL MTT medium showed no reduction of MTT as compared to the solvent. The mixture did not turn blue/purple. Therefore, NSMTT equalled 0%.

The mixture of 50 mg test item per 1 mL Aqua dest. and 2 mL isopropanol showed colouring as compared to the solvent. Since the mean relative tissue viability of the test item treated tissues (TM) was above the 60% threshold value coloured tissue controls were performed for quantitative correction of results.

NSCliving [%] = [ODTVT/ODNC] * 100 = 0.7%

Difference of NSCliving of the two duplicate tissues must be < 20%, otherwise not accepted.

NSC1 [%] = [ODTVT1 / ODNC] * 100 = 0.7%

NSC2 [%] = [ODTVT2 / ODNC] * 100 = 0.7%

NSC1 – NSC2 = ± 0.0%

NSCliving was ≤ 60% (0.7%) relative to the negative control of living epidermis and could therefore be used for determination of the NSC-corrected mean relative tissue viability (NSCCV) according to the following formula:

NSCCV [%] = viabilityTM [%] – NSCliving [%] = 108.7% - 0.7% = 108.0%

The test item showed no irritant effects. The mean relative tissue viability (% negative control) was > 60% (108.0%, NSCliving-corrected).